NCT01513772View on ClinicalTrials.gov

The Effect of Dexmedetomidine on the Emergence Agitation in Nasal Surgery

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions
Airway Extubation
Interventions
DRUG

Dexmedetomidine

Dexmedetomidine(4㎍/mL) : 0.4㎍/kg/hr infusion until extubation

DRUG

Normal saline 0.9%

Normal saline(guess as 4㎍/mL) : 0.4㎍/kg/hr infusion until extubation

Trial Locations (1)

Unknown

Department of Anesthesiology and Pain Medicine and Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul

All Listed Sponsors
lead

Severance Hospital

OTHER

NCT01513772 - The Effect of Dexmedetomidine on the Emergence Agitation in Nasal Surgery | Biotech Hunter | Biotech Hunter